Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.

about

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

P2860

Q26745838-F97C5C39-5202-406B-85F7-F6A692AD3111

P2860

Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.

Item

http://www.wikidata.org/entity/Q40230220

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Very late relapse of PTLD 10 y ...... ing immunosuppressive therapy.

@en

type

Item

label

Very late relapse of PTLD 10 y ...... ing immunosuppressive therapy.

@en

prefLabel

Very late relapse of PTLD 10 y ...... ing immunosuppressive therapy.

@en

P1476

Very late relapse of PTLD 10 y ...... ing immunosuppressive therapy.

@en

P2093

Carsten Heilmann

http://www.w3.org/2001/XMLSchema#string

Erik Østergaard

http://www.w3.org/2001/XMLSchema#string

Jon Helgestad

http://www.w3.org/2001/XMLSchema#string

Morten Høgild Pedersen

http://www.w3.org/2001/XMLSchema#string

Preben Johansen

http://www.w3.org/2001/XMLSchema#string

Steen Rosthøj

http://www.w3.org/2001/XMLSchema#string

Victor Iyer

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation.

Treatment advances in posttransplant lymphoproliferative disease.

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.

Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation.

Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute

P304

E35-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12180

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258146192

http://www.w3.org/2001/XMLSchema#string

P698

24168387

http://www.w3.org/2001/XMLSchema#string

Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.

about

P2860

P2860

Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698